abstract |
Phosphodiesterase 7. Inhibitor Heterocyclic Derivatives The present invention provides, on the one hand, a new series of compounds of general formula (I) and (II) # **** IMAGE **** # belonging to a broad family of derivatives Heterocyclic with activity for the treatment of diseases where PDE7 inhibition is therapeutic. Preferably for inflammatory, autoimmune and neurodegenerative diseases. On the other hand, heterocyclic compounds are described, as well as their procedure for obtaining them, and may be widely used as drugs or drug candidates. |